Form 4: ReposiTrak CEO Randall K. Fields Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4 Filing


ReposiTrak's CEO, Randall K. Fields, sold a total of 7,500 shares of common stock through a pre-arranged 10b5-1 trading plan.

Summary

  • Randall K. Fields, CEO of ReposiTrak, Inc., executed sales of common stock on November 18 and 19, 2024.
  • These sales were conducted under a pre-existing Rule 10b5-1 trading plan adopted on June 26, 2024.
  • On November 18, 4,500 shares were sold at a weighted average price of $21.9702, with individual prices ranging from $21.61 to $22.30.
  • On November 19, 3,000 shares were sold at a weighted average price of $22.5443, with individual prices ranging from $22.01 to $22.92.
  • The sales were made to meet some of the reporting person's charitable commitments.
  • Following these transactions, Mr. Fields continues to hold a significant number of shares both directly and indirectly through various entities.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock sales under a pre-arranged plan, which is neither positive nor negative in itself. The sales are for charitable purposes, which is a neutral factor.

Risks

  • The sale of shares by a key executive could be perceived negatively by the market, potentially impacting the stock price.

Management Comments

  • The trading plan was established to enable the Reporting Person to meet some of his charitable commitments.

Industry Context

Executive stock sales are a common occurrence, and the use of 10b5-1 plans is a standard practice to avoid accusations of insider trading. This filing is a routine disclosure of such activity.

Comparison to Industry Standards

  • The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies to manage their stock sales and avoid insider trading allegations.
  • The reported sales are within the typical range of executive stock transactions and do not appear to be unusual compared to similar filings from other companies.

Stakeholder Impact

  • The stock sales could have a minor impact on the share price, but the pre-arranged nature of the sales should mitigate any significant negative reaction from shareholders.

Key Dates

DateDescription
06/26/2024Date the 10b5-1 trading plan was adopted by the reporting person.
11/18/2024Date of the first reported sale of 4,500 shares.
11/19/2024Date of the second reported sale of 3,000 shares and date of the filing.

Keywords

ReposiTrak, Randall K. Fields, insider trading, Form 4, 10b5-1 trading plan, share sale, executive stock sale

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.